W. Rowlands

Director/Board Member at A-LABS CAPITAL II CORP.

62 year

Health Technology

Non-Energy Minerals

Finance

Profile

W.
Bruce Rowlands is an Independent Director at A-Labs Capital II Corp.
He was the Chairman of XORTX Therapeutics, Inc. from 2018 to 2021.
He was a Director at Talisker Resources Ltd.
in 2018.
He also served as a Director at XORTX Pharma Corp.
He was a Director & Vice President at Dominick & Dominick Securities, Inc. from 1999 to 2003.
He was the Senior Vice President-Planning & Public Affairs at Aptose Biosciences, Inc. from 2003 to 2005.
Currently, he holds the position of Independent Director at A-Labs Capital II Corp.

W. Rowlands active positions

Companies	Position	Start
A-LABS CAPITAL II CORP.	Director/Board Member	2018-09-04

All active positions of W. Rowlands

Former positions of W. Rowlands

Companies	Position	End
XORTX THERAPEUTICS INC.	Chairman	2021-12-19
TALISKER RESOURCES LTD.	Chief Executive Officer	2018-03-14
APTOSE BIOSCIENCES INC.	Public Communications Contact	2004-12-31
Dominick & Dominick Securities, Inc.	Director/Board Member	2002-12-31
XORTX Pharma Corp. XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada.	Director/Board Member	-

See the detail of W. Rowlands's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of W. Rowlands's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	4
APTOSE BIOSCIENCES INC.	Health Technology
TALISKER RESOURCES LTD.	Non-Energy Minerals
XORTX THERAPEUTICS INC.	Health Technology
A-LABS CAPITAL II CORP.	Finance

Private companies	2
XORTX Pharma Corp. XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada.	Health Technology
Dominick & Dominick Securities, Inc.